Omnicell Inc. reported its financial results for the third quarter ended September 30, 2025. The company posted total non-GAAP net income of $24.0 million, or $0.51 per diluted share, compared to $26.0 million, or $0.56 per diluted share, in the third quarter of 2024. Total non-GAAP EBITDA for the third quarter of 2025 was $41.0 million, up from $39.0 million in the same period last year. Cash and cash equivalents as of September 30, 2025, were $180.0 million, with total debt of $167.0 million and total assets of $1.9 billion. Cash flows from operating activities for the third quarter of 2025 were $28.0 million, compared to $23.0 million in the third quarter of 2024. During the third quarter, Omnicell repaid the remaining principal balance of $175.0 million in convertible senior notes that matured. The company highlighted its flagship point-of-care connected devices as the main driver of business during the period. For the full year, Omnicell provided non-GAAP EBITDA guidance of $140.0 million to $146.0 million and non-GAAP earnings per share guidance of $1.63 to $1.73.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Omnicell Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251030245772) on October 30, 2025, and is solely responsible for the information contained therein.
Comments